posted on 2010-11-25, 00:00authored byYing Fu, Abraha Habtemariam, Ana M. Pizarro, Sabine H. van Rijt, David J. Healey, Patricia A. Cooper, Steven D. Shnyder, Guy J. Clarkson, Peter J. Sadler
Iodido osmium(II) complexes [Os(η<sup>6</sup>-arene)(XY)I]<sup>+</sup> (XY = <i>p</i>-hydroxy or <i>p</i>-dimethylaminophenylazopyridine, arene = <i>p</i>-cymene or biphenyl) are potently cytotoxic at nanomolar concentrations toward a panel of human cancer cell lines; e.g., IC<sub>50</sub> = 140 nM for [Os(η<sup>6</sup>-bip)(azpy-NMe<sub>2</sub>)I]<sup>+</sup> toward A2780 ovarian cancer cells. They exhibit low toxicity and negligible deleterious effects in a colon cancer xenograft model, giving rise to the possibility of a broad therapeutic window. The most active complexes are stable and inert toward aquation. Their cytotoxic activity appears to involve redox mechanisms.